Skip to main content
SpringerLink
Log in

Common Diseases Which May Complicate the Osteoporosis Phenotype

  • Chapter
Osteoporosis: Genetics, Prevention and Treatment

Part of the book series: Endocrine Updates ((ENDO,volume 3))

  • 89 Accesses

Abstract

Osteoporosis is the commonest condition to affect the bony skeleton producing considerable morbidity and mortality to those who sustain fractures. The majority of those affected are post-menopausal women and elderly people of both sexes. Although the majority of sufferers of osteoporosis are otherwise healthy people, a variety of diseases are associated with osteoporosis and sometimes treatment instituted for a particular disease impacts upon the skeleton. It is important to determine where possible those factors which either produce or exacerbate osteoporosis. It is only by understanding how a disease might affect the skeleton that prevention and possible treatment strategies can be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lindsay R, Nieves J, Formica C, et al 1997 Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among post-menopausal women on estrogen with osteoporosis. Lancet 350: 550–555.

    Article  PubMed  CAS  Google Scholar 

  2. Lumb GA, Stanbury SW 1974 Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 56: 833–839.

    Article  PubMed  CAS  Google Scholar 

  3. Murray TM, Peacock M, Powell D, Monchik JM, Potts JT Jr 1972 Non-autonomy of hormone secretions in primary hyperparathyroidism. Clin Endocrinol 235–246.

    Google Scholar 

  4. Heath H III 1996 “Primary Hyperparathyroidism, Hyperparathyroid Bone Disease and Osteoporosis”. In Osteoporosis Marcus R, Feldman D, and Kelsey J eds Academic Press, San Diego 885–897.

    Google Scholar 

  5. Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW 1990 The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinaol Metab 70: 930–938.

    Article  CAS  Google Scholar 

  6. Mosekilde Le, Mosekilde L 1988 “Iliac crest trabecular bone compressive strength and ash weight is increased in moderate hyperparathyroidism”. In Bone-Morphometry (Proceedings of the Fifth International Congress on Bone Morphometry, Niigata, Japan). Takahashi HE, Ed. New York: Smith-Gordon 483.

    Google Scholar 

  7. Parisien M, Mellish RWE, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW 1992 Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis. J Bone Miner Res 913–919.

    Google Scholar 

  8. Van Doom L, Lips P, Nettelenbos JC, Hackengt WHL 1989 Bone histomorphometry and serum intact PTH (1-84) in hyperparathyroid patients. Calcif Tissue Inter 44S: N36.

    Google Scholar 

  9. Adams JE, Whitehouse RW, Adams PH, Davies M 1990 The effects of primary hyperparathyroidism on trabecular and cortical bone mass. Calcif Tissue Res 46: 144.

    Google Scholar 

  10. Silverberg SJ, Shane E, De La Cruz L, et al 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4: 283–291.

    Article  PubMed  CAS  Google Scholar 

  11. Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I 1993 The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow up of 19 years. J Intern Med 234: 585–593.

    Article  PubMed  CAS  Google Scholar 

  12. Dauphine RT, Riggs BL, Scholz DA 1975 Backpain and vertebral crush fractures: An unemphasized mode of presentation for primary hyperparathyroidism. Ann Intern Med 83: 365–367.

    PubMed  CAS  Google Scholar 

  13. Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J, Lyles KW 1987 What is the significance of bone loss in primary hyperparathyroidism. Ann Intern Med 83: 365–367.

    Google Scholar 

  14. Heath H III, Hogdson SF, Kennedy MA 1980 Primary hyperparathyroidism: Incidence, morbidity and economic impact in a community. N Engl J Med 302: 189–193.

    Article  PubMed  Google Scholar 

  15. Silverberg SJ, Locker FG, Bilezikian JP 1996 Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81: 4007–4012.

    Article  PubMed  CAS  Google Scholar 

  16. Silverberg SJ, Gratenberg F, Jacobs TP, 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80: 729–734.

    Article  PubMed  CAS  Google Scholar 

  17. Wishart J, Horowitz M, Need A, Chatterton B, Nordin BEC 1990 Treatment of post-menopausal hyperparathyroidism with norethindrone. Long term effects on forearm bone mineral content. Arch Intern Med 150: 1951–1953.

    Article  PubMed  CAS  Google Scholar 

  18. Nemeth EF 1995 Ca2+ receptor-dependent regulation and cellular functions. News Physiol Sci 1995 10: 1–5.

    CAS  Google Scholar 

  19. Eriksen FF, Mosekilde L, Meisen F 1985 Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6: 421–428.

    Article  PubMed  CAS  Google Scholar 

  20. Bouillon R, Muls E, Demoor P 1980 Influence of thyroid function on the serum concentration of 1,25 dihydroxyvitamin D3. J Clin Endocrinol Metab 51: 793–797.

    Article  PubMed  CAS  Google Scholar 

  21. Linde J, Friis T 1979 Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol 91: 437–448.

    PubMed  CAS  Google Scholar 

  22. Cummings SR, Nevitt MC, Browner WS, et al 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332: 767–773.

    Article  PubMed  CAS  Google Scholar 

  23. Solomon BL, Wartofsky L, Burman KD. 1993 Prevalence of fractures in post-menopausal women with thyroid disease. Thyroid 3: 17–23.

    Article  PubMed  CAS  Google Scholar 

  24. Rosen CJ, Alder RA 1992 Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75: 1531–1534.

    Article  PubMed  CAS  Google Scholar 

  25. Grant DJ, McMurdo MET, Mole PA, Paterson CR 1995 Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 43: 339–345.

    Article  CAS  Google Scholar 

  26. Faber J, Gallos AE 1994 Changes in bone mass during prolonged sub-clinical hyperthyroidism due to L-thyroxine treatment. A metaanalysis. Eur J Endocrinol 130: 350–356.

    Article  PubMed  CAS  Google Scholar 

  27. Compston JE 1993 Thyroid hormone replacement therapy and the skeleton. Clin Endocrinol 39: 519–520.

    Article  CAS  Google Scholar 

  28. Guo CY, Weetman AP, Eastell R 1997 Longitudinal changes of bone mineral density and bone turnover in post-menopausal women on thyroxine. Clin Endocrinol 46: 301–307.

    Article  CAS  Google Scholar 

  29. Rosen HN, Moses AC, Gundberg C, et al 1993 Therapy with parenteral pamidronate prevents thyroid hormone induced bone turnover in humans. J Clin Endocrinol Metab 77: 664–669.

    Article  PubMed  CAS  Google Scholar 

  30. Stanbury SW, Taylor CM, Lumb GA, Mawer EB, Berry J, Hann J, Wallace J 1981 Formation of vitamin D metabolites following correction of human vitamin D deficiency. Miner Electrolyte Metab 5: 212–227.

    Google Scholar 

  31. Morrison NA, Qi JC, Tokita A, et al 1994 Prediction of bone density by vitamin D receptor alleles. Nature 367: 284–287.

    Article  PubMed  CAS  Google Scholar 

  32. Chapuy MC, Meunier PJ. “Vitamin D Insufficiency in adults and the elderly”. In Vitamin D Feldman D, Glorieux PH, Pike JW, eds Academic Press, San Diego, London, Sydney, Toronto 679–693.

    Google Scholar 

  33. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hereberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7: 439–443.

    Article  PubMed  CAS  Google Scholar 

  34. Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, Adams PH. 1992 The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol 37: 17–27.

    Article  CAS  Google Scholar 

  35. Davies M, Heys SE, Selby PL, Berry JL, Mawer EB. 1997 Increased catabolism of 25 hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25 dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 82: 209–212.

    Article  PubMed  CAS  Google Scholar 

  36. Clements MR, Johnson L, Fraser DR 1987 A new mechanism for induced vitamin D deficiency in calcium deprivation 325: 62–6

    CAS  Google Scholar 

  37. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ, 1996 Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81: 1129–1133.

    Article  PubMed  CAS  Google Scholar 

  38. Brazier M, Kamel S, Maamer M, et al 1995 Markers of bone remodeling in elderly subjects. Effects of vitamin D insufficiency and its correction. J Bone Miner Res 10: 1753–1761.

    Article  PubMed  CAS  Google Scholar 

  39. Khaw KT, Sheyd MJ, Compston J 1992 Bone density parathyroid hormone and 25 hydroxyvitamin D concentrations in middle aged women. Br Med J 305: 273–277.

    Article  CAS  Google Scholar 

  40. Ooms ME, Roos JC, Bezemer PD, Van Der Vijch WJF, Bouter LM, Lips P 1995 Prevention of bone loss by vitamin D supplementation in elderly women. J Clin Endocrinol Metab 80: 1052–1058.

    Article  PubMed  CAS  Google Scholar 

  41. Comptson JE, Silver AC, Croucher PI, Brown RC, Woodhead JS 1989 Elevated serum intact parathyroid hormone levels in elderly patients with hip fracture. Clin Endocrinol 31: 667–672.

    Article  Google Scholar 

  42. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, et al 1992 Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327: 1637–1642.

    Article  PubMed  CAS  Google Scholar 

  43. Himmelstein S, Clemens TL, Rubin A, Lindsay R 1990 Vitamin D supplementation in elderly nursing home residents increases 25OHD but not 1,25(OH)2D. Am J Clin Nutr 2: 701–706.

    Google Scholar 

  44. Dawson-Hughes B, Dallai GE, Krall EA, Harris S, Sokoll LJ, Falconer G 1991 Effect of vitamin D supplementation on overall bone loss in healthy post-menopausal women. Ann Intern Med 115: 505–512.

    PubMed  CAS  Google Scholar 

  45. Dawson-Hughes B, Harris SS, Krall EA, Dalllal GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337: 670–676.

    Article  PubMed  CAS  Google Scholar 

  46. Heikinheimo RJ, Inkovaara JA, Harju EJ, et al 1992 Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51: 105–110.

    Article  PubMed  CAS  Google Scholar 

  47. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM 1996 Vitamin D supplementation and fracture incidence in elderly persons: a randomised placebo-controlled clinical trial. Ann Intern Med 124: 400–406.

    PubMed  CAS  Google Scholar 

  48. Chevalley T, Rizzoli R, Nydegger V, et al 1994 Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin D replete elderly patients. Osteoporos Int 4: 245–252.

    Article  PubMed  CAS  Google Scholar 

  49. Recker RR, Hinders S, Davies KM, et al 1996 Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11: 1961–1966.

    Article  PubMed  CAS  Google Scholar 

  50. 1993 Consensus Development Conference: Diagnosis, Prophylaxis and Treatment of Osteoporosis. Am J Med 94: 646–650.

    Google Scholar 

  51. Colston KW, MacKay AG, Finlayson C, Wu JCY, Maxwell JD 1994 Localisation of vitamin D receptor in normal human duodenum and in patients with celiac disease. Gut 35: 1219–1225.

    Article  PubMed  CAS  Google Scholar 

  52. Arnaud SB, Goldsmith RS, Lambert PW, Go VLW 1975 25 hydroxyvitamin D3. Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol 149: 570–572.

    PubMed  CAS  Google Scholar 

  53. Glascon-Barre M 1986 Is there any physiological significance to the enterohepatic circulation of vitamin D sterols? J Am College Nutr 5: 317–324.

    Google Scholar 

  54. Hodges SJ, Pilkington MJ, Stamp TCB, et al 1991 Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12: 387–389.

    Article  PubMed  CAS  Google Scholar 

  55. Vermeer C, Jie KSG, Knapen MHJ, et al 1995 Role of vitamin K in bone metabolism. Annu Rev Nutr 15: 1–22.

    Article  PubMed  CAS  Google Scholar 

  56. Nilas L, Christiansen C, Christiansen J 1985 Regulation of vitamin D and calcium metabolism after gastrectomy. Gut 26: 252–257.

    Article  PubMed  CAS  Google Scholar 

  57. Mellstrom D, Johansson C, Johnell O, et al 1993 Osteoporosis, metabolic aberrations and increased risk of vertebral fractures after partial gastrectomy. Calcif Tissue Int 53: 370–377.

    PubMed  CAS  Google Scholar 

  58. Walters JRF 1994 Bone mineral density in celiac disease. Gut 150–151.

    Google Scholar 

  59. Lindh E, Ljunghall S, Larsson K, Lavo B 1992 Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 231: 403–406.

    Article  PubMed  CAS  Google Scholar 

  60. McFarlane J, Bhalla A, Morgan L, Reeves D, Robertson DAF 1992 Osteoporosis: A frequent finding in treated adult celiac disease. Gut 33: S48.

    Article  Google Scholar 

  61. Butcher GP, Banks LM, Walters JRF 1992 Reduced bone mineral density in celiac disease — the need for densitometry estimations, Gut 33: S54.

    Google Scholar 

  62. Molteni N, Caraceni MP, Bardella MT, Ortolani S, Ganddlini GG, Bianchi P 1990 Bone mineral density in adult celiac patients and the effect of gluten free diet from childhood. Am J Gastroenterol 85: 51–53.

    PubMed  CAS  Google Scholar 

  63. Corazza GR, Disario A, Ceochetti L, et al 1995 bone mass and metabolism in patients with celiac disease. Gastroenterology 109: 122–128.

    Article  PubMed  CAS  Google Scholar 

  64. Selby PL, Davies M, Warnes TW, Adams JE, Mawer EB 1995 Bone metabolism in celiac disease. J Bone Miner Res 10: S507.

    Google Scholar 

  65. Compston JE, Judd D, Crawley EO, et al 1987 Osteoporosis in patients with inflammatory bowel disease. Gut 28: 410–415.

    Article  PubMed  CAS  Google Scholar 

  66. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH 1982 Vitamin D deficiency and bone disease in patients with Crohn’s. Gastroenterology 83: 1252–1258.

    PubMed  Google Scholar 

  67. Krawitt EL, Grundman MJ, Mawer EB 1977 Absorption hydroxylation and excretion of vitamin D3 in primary biliary cirrhosis. Lancet 2: 1246–1249.

    Article  PubMed  CAS  Google Scholar 

  68. Mawer EB, Klass HJ, Warnes TW, Berry JL 1985 Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci 69: 561–570.

    PubMed  CAS  Google Scholar 

  69. Lindor KD, James CH, Crippin JS, Jorgenson RA, Dickson ER 1995 Bone disease in primary biliary cirrhosis. Does urodeoxycholic acid make a difference? Hepatology 21: 389–392.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael Davies M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai Medical Center, Los Angeles, California, USA

    John S. Adams M.D.

  2. University of Kansas Medical School, Kansas City, Missouri, USA

    Barbara P. Lukert M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Davies, M. (1999). Common Diseases Which May Complicate the Osteoporosis Phenotype. In: Adams, J.S., Lukert, B.P. (eds) Osteoporosis: Genetics, Prevention and Treatment. Endocrine Updates, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5115-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5115-7_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7327-8

  • Online ISBN: 978-1-4615-5115-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation